Fibroblast-like synoviocytes from patients with rheumatoid arthritis are more sensitive to apoptosis induced by the viral protein, apoptin, than fibroblast-like synoviocytes from trauma patients.
暂无分享,去创建一个
R. Toes | R. Nelissen | T. Huizinga | N. Henriquez | M. Noteborn | Y-H Zhang | T. Tolboom
[1] M. Noteborn. Apoptin acts as a tumor-specific killer: potentials for an anti-tumor therapy. , 2005, Cellular and molecular biology.
[2] Michael R. Green,et al. The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. , 2004, Genes & development.
[3] J. Rohn,et al. The viral death effector Apoptin reveals tumor-specific processes , 2004, Apoptosis.
[4] J. Rohn,et al. Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing , 2004, Cell Death and Differentiation.
[5] H. Tanke,et al. Recombinant Apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in a normal-cell-specific fashion. , 2003, Experimental cell research.
[6] J. Abrahams,et al. Importance of Nuclear Localization of Apoptin for Tumor-specific Induction of Apoptosis* , 2003, Journal of Biological Chemistry.
[7] J. Abrahams,et al. Apoptin Induces Tumor-specific Apoptosis as a Globular Multimer* , 2003, The Journal of Biological Chemistry.
[8] J. Rohn,et al. A Tumor-specific Kinase Activity Regulates the Viral Death Protein Apoptin* , 2002, The Journal of Biological Chemistry.
[9] R. Toes,et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 , 2002, Annals of the rheumatic diseases.
[10] M. Noteborn,et al. The Chicken Anemia Virus-Derived Protein Apoptin Requires Activation of Caspases for Induction of Apoptosis in Human Tumor Cells , 2000, Journal of Virology.
[11] P. J. Abrahams,et al. The viral protein Apoptin induces apoptosis in UV-C-irradiated cells from individuals with various hereditary cancer-prone syndromes. , 1999, Cancer research.
[12] T. Kobata,et al. Apomodulation as a novel therapeutic concept for the regulation of apoptosis in rheumatoid synoviocytes. , 1999, Current opinion in rheumatology.
[13] P. Kuppen,et al. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene , 1999, Gene Therapy.
[14] M. Tamulaitienė,et al. A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. , 1999, Rheumatology.
[15] A. van der Eb,et al. Apoptin specifically causes apoptosis in tumor cells and after UV-treatment in untransformed cells from cancer-prone individuals: a review. , 1998, Mutation research.
[16] J. Kriegsmann,et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. , 1996, The American journal of pathology.
[17] U. Müller-Ladner,et al. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. , 1996, The Journal of rheumatology.
[18] S. Yamashita,et al. Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.
[19] G. Firestein,et al. Apoptosis in rheumatoid arthritis synovium. , 1995, The Journal of clinical investigation.
[20] U. Müller-Ladner,et al. Oncogenes in rheumatoid arthritis. , 1995, Rheumatic diseases clinics of North America.
[21] R. Gay,et al. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. , 1994, Journal of immunology.
[22] M. Kohli,et al. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. , 1994, Arthritis and rheumatism.
[23] M. Sporn,et al. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. , 1989, The Journal of clinical investigation.